Search Results - "Hurst, C."

Refine Results
  1. 1

    Commissioning of the Varian TrueBeam linear accelerator: A multi-institutional study by Glide-Hurst, C., Bellon, M., Foster, R., Altunbas, C., Speiser, M., Altman, M., Westerly, D., Wen, N., Zhao, B., Miften, M., Chetty, I. J., Solberg, T.

    Published in Medical physics (Lancaster) (01-03-2013)
    “…Purpose: Latest generation linear accelerators (linacs), i.e., TrueBeam (Varian Medical Systems, Palo Alto, CA) and its stereotactic counterpart, TrueBeam STx,…”
    Get full text
    Journal Article
  2. 2

    Changes realized from extended bit-depth and metal artifact reduction in CT by Glide-Hurst, C., Chen, D., Zhong, H., Chetty, I. J.

    Published in Medical physics (Lancaster) (01-06-2013)
    “…Purpose: High-Z material in computed tomography (CT) yields metal artifacts that degrade image quality and may cause substantial errors in dose calculation…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Definitions matter: detection rates and perinatal outcome for infants classified prenatally as having late fetal growth restriction using SMFM biometric vs ISUOG/Delphi consensus criteria by Schreiber, V., Hurst, C., Silva Costa, F., Stoke, R., Turner, J., Kumar, S.

    Published in Ultrasound in obstetrics & gynecology (01-03-2023)
    “…Objectives Fetal growth restriction (FGR) is often secondary to placental dysfunction and is suspected prenatally based on biometric or circulatory…”
    Get full text
    Journal Article
  5. 5

    RGS14 limits seizure-induced mitochondrial oxidative stress and pathology in hippocampus by Harbin, N.H., Lustberg, D.J., Hurst, C., Pare, J., Crotty, K.M., Waters, A.L., Yeligar, S.M., Smith, Y., Seyfried, N.T., Weinshenker, D., Hepler, J.R.

    Published in Neurobiology of disease (01-06-2023)
    “…RGS14 is a complex multifunctional scaffolding protein that is highly enriched within pyramidal cells (PCs) of hippocampal area CA2. In these neurons, RGS14…”
    Get full text
    Journal Article
  6. 6

    TU‐F‐BRB‐03: Clinical Implementation of MR‐Based Motion Management by Glide‐Hurst, C.

    Published in Medical physics (Lancaster) (01-06-2015)
    “…The current clinical standard of organ respiratory imaging, 4D‐CT, is fundamentally limited by poor soft‐tissue contrast and imaging dose. These limitations…”
    Get full text
    Journal Article
  7. 7

    MO-DE-207A-03: Characterization of Potential Gains in a Novel Exponential 4DCT Reconstruction Algorithm by Morris, E.D., Klahr, P., Glide-Hurst, C.

    Published in Medical physics (Lancaster) (01-06-2016)
    “…Purpose: To sample the breathing cycle and obtain accurate target volumes, 4DCT requires the entire field of view (FOV) to be illuminated during one breathing…”
    Get full text
    Journal Article
  8. 8

    Knockdown by shRNA identifies S249C mutant FGFR3 as a potential therapeutic target in bladder cancer by TOMLINSON, D. C, HURST, C. D, KNOWLES, M. A

    Published in Oncogene (30-08-2007)
    “…More than 60% of low-grade non-invasive papillary urothelial cell carcinomas contain activating point mutations of fibroblast growth factor receptor 3 (FGFR3)…”
    Get full text
    Journal Article
  9. 9

    Applying the Clinician-reported Genetic testing Utility InDEx (C-GUIDE) to genome sequencing: further evidence of validity by Hayeems, Robin Z, Luca, Stephanie, Hurst, Anna C E, Cochran, Meagan, Owens, Chelsea, Hossain, Alomgir, Chad, Lauren, Meyn, M Stephen, Pullenayegum, Eleanor, Ungar, Wendy J, Bick, David

    Published in European journal of human genetics : EJHG (01-12-2022)
    “…Genome sequencing (GS) outperforms other rare disease diagnostics, but standardized approaches to assessing its clinical utility are limited. This study…”
    Get full text
    Journal Article
  10. 10

    Do improvements in clinical practice guidelines alter pregnancy outcomes in asthmatic women? A single-center retrospective cohort study by Robinson, J. L., Gatford, K. L., Hurst, C. P., Clifton, V. L., Morrison, J. L., Stark, M. J.

    Published in The Journal of asthma (03-10-2023)
    “…Asthma occurs in ∼17% of Australian pregnancies and is associated with adverse perinatal outcomes, which worsen with poor asthma control. Consequently, the…”
    Get full text
    Journal Article
  11. 11

    CD4 count and risk of anti-tuberculosis drug-associated cutaneous reactions in HIV-infected Thai patients by Boonyagars, L., Hirunwiwatkul, P., Hurst, C. P.

    “…OBJECTIVES: Tuberculosis (TB) is a major cause of morbidity and mortality in human immunodeficiency virus (HIV) infected patients. However, anti-tuberculosis…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    PIK3CA dependence and sensitivity to therapeutic targeting in urothelial carcinoma by Ross, R L, McPherson, H R, Kettlewell, L, Shnyder, S D, Hurst, C D, Alder, O, Knowles, M A

    Published in BMC cancer (28-07-2016)
    “…Many urothelial carcinomas (UC) contain activating PIK3CA mutations. In telomerase-immortalized normal urothelial cells (TERT-NHUC), ectopic expression of…”
    Get full text
    Journal Article
  15. 15

    Advancing our understanding of skeletal muscle across the lifecourse: Protocol for the MASS_Lifecourse study and characteristics of the first 80 participants by Dodds, R.M., Hurst, C., Hillman, S.J., Davies, K., Roberts, L., Aspray, T.J., Granic, A., Sayer, A.A.

    Published in Experimental gerontology (01-09-2022)
    “…Sarcopenia, the age-related loss of skeletal muscle strength and mass, carries a significant burden for affected individuals. There has been little…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Reactive skin decontamination lotion (RSDL) for the decontamination of chemical warfare agent (CWA) dermal exposure by Schwartz, M D, Hurst, C G, Kirk, M A, Reedy, S J D, Braue, Jr, E H

    Published in Current pharmaceutical biotechnology (01-08-2012)
    “…Rapid decontamination of the skin is the single most important action to prevent dermal absorption of chemical contaminants in persons exposed to chemical…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Efficacy and Safety of Injectable Mixed Collagenase Subtypes in the Treatment of Dupuytren’s Contracture by Badalamente, Marie A., PhD, Hurst, Lawrence C., MD

    Published in The Journal of hand surgery (American ed.) (01-07-2007)
    “…Purpose To further evaluate the efficacy and safety of an injectable mixed subtype collagenase for the treatment of Dupuytren’s contracture (DC). Methods…”
    Get full text
    Journal Article
  20. 20

    SU-G-IeP2-07: Investigation of 3D-Printed Phantoms for Synthetic CT Benchmarking in An MR-Only Workflow by Kim, J, Myers, E, Forbes, M, Chetty, I, Glide-Hurst, C

    Published in Medical physics (Lancaster) (01-06-2016)
    “…Purpose: As we move toward MR-only treatment planning, a need exists to develop multi-modality phantoms to benchmark synthetic CT (synCT) generation. We…”
    Get full text
    Journal Article